{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T04:01:13Z","timestamp":1725854473443},"publisher-location":"Cham","reference-count":78,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319221076"},{"type":"electronic","value":"9783319221083"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/5584_2016_108","type":"book-chapter","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T10:19:12Z","timestamp":1472811552000},"page":"89-100","source":"Crossref","is-referenced-by-count":0,"title":["The Optimal Duration of Anticoagulation in Patients with Unprovoked Venous Thromboembolism"],"prefix":"10.1007","author":[{"given":"Paolo","family":"Prandoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,13]]},"reference":[{"key":"108_CR1","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1742-1241.2010.02439.x","volume":"64","author":"V Agarwal","year":"2010","unstructured":"Agarwal V, Phung OJ, Tongbram V, Bhardwaj A, Coleman CI (2010) Statin use and the prevention of venous thromboembolism: a meta-analysis. Int J Clin Pract 64:1375\u20131383","journal-title":"Int J Clin Pract"},{"key":"108_CR2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","volume":"368","author":"G Agnelli","year":"2013","unstructured":"Agnelli G, Buller HR, Cohen A et al (2013a) Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 368:699\u2013708","journal-title":"N Engl J Med"},{"key":"108_CR3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","volume":"368","author":"G Agnelli","year":"2013","unstructured":"Agnelli G, Buller HR, Cohen A et al (2013b) Apixaban for extended treatment of venous thromboembolism. N Engl J Med 368:699\u2013708","journal-title":"N Engl J Med"},{"key":"108_CR4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(03)14111-6","volume":"362","author":"T Baglin","year":"2003","unstructured":"Baglin T, Luddington R, Brown K, Baglin C (2003) Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 362:523\u2013526","journal-title":"Lancet"},{"key":"108_CR5","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1111\/j.1538-7836.2010.04022.x","volume":"8","author":"T Baglin","year":"2010","unstructured":"Baglin T, Douketis J, Tosetto A et al (2010) Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient level meta-analysis. J Thromb Haemost 8:2436\u20132442","journal-title":"J Thromb Haemost"},{"doi-asserted-by":"crossref","unstructured":"Becattini C, Agnelli G, Schenone et al (2012) Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 366:1959\u20131967","key":"108_CR6","DOI":"10.1056\/NEJMoa1114238"},{"key":"108_CR7","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/eurheartj\/eht046","volume":"34","author":"S Biere-Rafi","year":"2013","unstructured":"Biere-Rafi S, Hutten BA, Squizzato A et al (2013) Statin treatment and the risk of recurrent pulmonary embolism. Eur Heart J 34:1800\u20131806","journal-title":"Eur Heart J"},{"key":"108_CR8","doi-asserted-by":"crossref","first-page":"d3036","DOI":"10.1136\/bmj.d3036","volume":"342","author":"F Boutitie","year":"2011","unstructured":"Boutitie F, Pinede L, Schulman S et al (2011) Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants\u2019 data from seven trials. BMJ 342:d3036","journal-title":"BMJ"},{"key":"108_CR9","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMoa1210384","volume":"367","author":"TA Brighton","year":"2012","unstructured":"Brighton TA, Eikelboom JW, Mann K et al (2012) Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 367:1979\u20131987","journal-title":"N Engl J Med"},{"key":"108_CR10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1538-7836.2009.03293.x","volume":"7","author":"E Bruinstroop","year":"2009","unstructured":"Bruinstroop E, Klok FA, van de Ree MA, Oosterwijk FL, Huisman MV (2009) Elevated D-dimer levels predict recurrence in patients with idiopathic venous thromboembolism: a meta-analysis. J Thromb Haemost 7:611\u2013618","journal-title":"J Thromb Haemost"},{"key":"108_CR11","doi-asserted-by":"crossref","first-page":"578","DOI":"10.7326\/0003-4819-152-9-201005040-00008","volume":"152","author":"M Carrier","year":"2010","unstructured":"Carrier M, Le Gal G, Wells PS, Rodger MA (2010) Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med 152:578\u2013589","journal-title":"Ann Intern Med"},{"key":"108_CR12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood-2009-08-237354","volume":"115","author":"B Cosmi","year":"2010","unstructured":"Cosmi B, Legnani C, Tosetto A et al (2010) Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study. Blood 115:481\u2013488","journal-title":"Blood"},{"key":"108_CR13","first-page":"695","volume":"91","author":"V Stefano De","year":"2006","unstructured":"De Stefano V, Simioni P, Rossi E et al (2006) The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S. Haematologica 91:695\u2013698","journal-title":"Haematologica"},{"key":"108_CR14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/CIRCULATIONAHA.113.003756","volume":"129","author":"MN Minno Di","year":"2014","unstructured":"Di Minno MN, Dentali F, Lupoli R, Ageno W (2014) Mild antithrombin deficiency and the risk of recurrent venous thromboembolism: a prospective cohort study. Circulation 129:497\u2013503","journal-title":"Circulation"},{"key":"108_CR15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1160\/TH13-04-0336","volume":"111","author":"MP Donadini","year":"2014","unstructured":"Donadini MP, Ageno W, Antonucci E et al (2014) Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis. A patient-level meta-analysis. Thromb Haemost 111:172\u2013179","journal-title":"Thromb Haemost"},{"key":"108_CR16","doi-asserted-by":"crossref","first-page":"d813","DOI":"10.1136\/bmj.d813","volume":"342","author":"J Douketis","year":"2011","unstructured":"Douketis J, Tosetto A, Marcucci M et al (2011) Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. BMJ 342:d813","journal-title":"BMJ"},{"key":"108_CR17","first-page":"566","volume":"80","author":"S Eichinger","year":"1998","unstructured":"Eichinger S, St\u00fcmpflen A, Hirschl M et al (1998) Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism. Thromb Haemost 80:566\u2013569","journal-title":"Thromb Haemost"},{"key":"108_CR18","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jama.290.8.1071","volume":"290","author":"S Eichinger","year":"2003","unstructured":"Eichinger S, Minar E, Bialonczyk C et al (2003) D-dimer levels and risk of recurrent venous thromboembolism. JAMA 290:1071\u20131074","journal-title":"JAMA"},{"key":"108_CR19","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1001\/archinte.168.15.1678","volume":"68","author":"S Eichinger","year":"2008","unstructured":"Eichinger S, Hron G, Bialonczyk C et al (2008) Overweight, obesity, and the risk of recurrent venous thromboembolism. Arch Intern Med 68:1678\u20131683","journal-title":"Arch Intern Med"},{"key":"108_CR20","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.109.925214","volume":"121","author":"S Eichinger","year":"2010","unstructured":"Eichinger S, Heinze G, Jandeck LM, Kyrle PA (2010) Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism. The Vienna prediction model. Circulation 121:1630\u20131636","journal-title":"Circulation"},{"key":"108_CR21","first-page":"85","volume":"88","author":"L Eischer","year":"2008","unstructured":"Eischer L, Gartner V, Schulman S, Kyrle PA, Eichinger S (2008) 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII. Ann Hematol 88:85\u201390","journal-title":"Ann Hematol"},{"key":"108_CR22","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/MD.0b013e3181c29e31","volume":"88","author":"L Eischer","year":"2009","unstructured":"Eischer L, Eichinger S, Kyrle PA (2009) Age at first venous thromboembolism and risk of recurrence: a prospective cohort study. Medicine (Baltimore) 88:366\u2013370","journal-title":"Medicine (Baltimore)"},{"key":"108_CR23","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1160\/TH13-06-0488","volume":"110","author":"E G\u00e1ndara","year":"2013","unstructured":"G\u00e1ndara E, Kovacs MJ, Kahn SR et al (2013) Non-O blood type influences the risk of recurrent venous thromboembolism. A cohort study. Thromb Haemost 110:1172\u20131179","journal-title":"Thromb Haemost"},{"key":"108_CR24","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/jth.12048","volume":"11","author":"K Gauthier","year":"2013","unstructured":"Gauthier K, Kovacs MJ, Wells PS, LE Gal G, Rodge M (2013) Family history of venous thromboembolism (VTE) as a predictor for recurrent VTE in unprovoked VTE patients. J Thromb Haemost 11:200\u2013203","journal-title":"J Thromb Haemost"},{"key":"108_CR25","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1258\/ar.2012.110697","volume":"53","author":"R Golpe","year":"2012","unstructured":"Golpe R, de Llano LA, Castro-A\u00f1\u00f3n O, V\u00e1zquez-Caruncho M, Gonz\u00e1lez-Juanatey C, Fari\u00f1as MC (2012) Long-term outcome of patients with persistent vascular obstruction on computed tomography pulmonary angiography 6 months after acute pulmonary embolism. Acta Radiol 53:728\u2013731","journal-title":"Acta Radiol"},{"key":"108_CR26","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archinte.160.6.769","volume":"1260","author":"PO Hansson","year":"2000","unstructured":"Hansson PO, Sorbo J, Eriksson H (2000) Recurrent venous thromboembolism after deep vein thrombosis. Incidence and risk factors. Arch Intern Med 1260:769\u2013774","journal-title":"Arch Intern Med"},{"key":"108_CR27","first-page":"540386","volume":"2010","author":"AB Holley","year":"2010","unstructured":"Holley AB, King CS, Jackson JL, Moores LK (2010) Different finite durations of anticoagulation and outcomes following idiopathic venous thromboembolism: a meta-analysis. Thromb J 2010:540386","journal-title":"Thromb J"},{"key":"108_CR28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.amjmed.2005.04.043","volume":"119","author":"G Hron","year":"2006","unstructured":"Hron G, Eichinger S, Weltermann A et al (2006) Family history for venous thromboembolism and the risk for recurrence. Am J Med 119:50\u201353","journal-title":"Am J Med"},{"key":"108_CR29","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1538-7836.2004.00698.x","volume":"2","author":"C Kearon","year":"2004","unstructured":"Kearon C, Ginsberg JS, Anderson DR et al (2004) Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. J Thromb Haemost 2:743\u2013749","journal-title":"J Thromb Haemost"},{"key":"108_CR30","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1182\/blood-2008-06-163279","volume":"112","author":"C Kearon","year":"2008","unstructured":"Kearon C, Julian JA, Kovacs MJ et al (2008) Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial. Blood 112:4432\u20134436","journal-title":"Blood"},{"issue":"2 Suppl","key":"108_CR31","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","volume":"141","author":"C Kearon","year":"2012","unstructured":"Kearon C, Akl EA, Comerota AJ et al (2012) Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e419S\u2013e494S","journal-title":"Chest"},{"key":"108_CR32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/M14-1275","volume":"162","author":"C Kearon","year":"2015","unstructured":"Kearon C, Spencer FA, O\u2019Keeffe D et al (2015) D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy. Ann Intern Med 162:27\u201334","journal-title":"Ann Intern Med"},{"key":"108_CR33","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/j.1538-7836.2010.03958.x","volume":"8","author":"MJ Kovacs","year":"2010","unstructured":"Kovacs MJ, Kahn SR, Wells PS et al (2010) Patients with a first symptomatic unprovoked DVT are at higher risk of recurrent VTE than patients with a first unprovoked PE. J Thromb Haemost 8:1926\u20131932","journal-title":"J Thromb Haemost"},{"key":"108_CR34","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1160\/TH12-05-0353","volume":"108","author":"PA Kyrle","year":"2012","unstructured":"Kyrle PA, Eichinger S (2012) Clinical scores to predict recurrence risk of venous thromboembolism. Thromb Haemost 108:1061\u20131064","journal-title":"Thromb Haemost"},{"key":"108_CR35","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJM200008173430702","volume":"343","author":"PA Kyrle","year":"2000","unstructured":"Kyrle PA, Minar E, Hirschl M et al (2000) High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 343:457\u2013462","journal-title":"N Engl J Med"},{"key":"108_CR36","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMoa032959","volume":"350","author":"PA Kyrle","year":"2004","unstructured":"Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S (2004) The risk of recurrent venous thromboembolism in men and women. N Engl J Med 350:2558\u20132563","journal-title":"N Engl J Med"},{"key":"108_CR37","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1160\/TH09-10-0685","volume":"104","author":"G Gal Le","year":"2010","unstructured":"Le Gal G, Kovacs MJ, Carrier M et al (2010) Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study. Thromb Haemost 104:498\u2013503","journal-title":"Thromb Haemost"},{"key":"108_CR38","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1160\/TH13-02-0132","volume":"110","author":"R Lecumberri","year":"2013","unstructured":"Lecumberri R, Alfonso A, Jim\u00e9nez D et al (2013) Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism. Thromb Haemost 110:834\u2013843","journal-title":"Thromb Haemost"},{"key":"108_CR39","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood-2009-04-215418","volume":"114","author":"WM Lijfering","year":"2009","unstructured":"Lijfering WM, Veeger NJ, Middeldorp S et al (2009) A lower risk of recurrent venous thrombosis in women compared to men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families. Blood 114:2031\u20132036","journal-title":"Blood"},{"key":"108_CR40","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/CIRCULATIONAHA.109.906347","volume":"121","author":"WM Lijfering","year":"2010","unstructured":"Lijfering WM, Middeldorp S, Veeger NJ et al (2010) Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A. Circulation 121:1706\u20131712","journal-title":"Circulation"},{"key":"108_CR41","first-page":"1046","volume":"91","author":"L L\u00f3pez-Jim\u00e9nez","year":"2006","unstructured":"L\u00f3pez-Jim\u00e9nez L, Montero M, Gonz\u00e1lez-Fajardo JA et al (2006) Venous thromboembolism in very elderly patients: findings from a prospective registry. Haematologica 91:1046\u20131051","journal-title":"Haematologica"},{"key":"108_CR42","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0140-6736(06)69110-1","volume":"368","author":"S McRae","year":"2006","unstructured":"McRae S, Tran H, Schulman S, Ginsberg J, Kearon C (2006) Effect of patient\u2019s sex on risk of recurrent venous thromboembolism: a meta-analysis. Lancet 368:371\u2013378","journal-title":"Lancet"},{"key":"108_CR43","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1111\/j.1538-7836.2012.04865.x","volume":"10","author":"M Milan","year":"2012","unstructured":"Milan M, Noventa F, Ghirarduzzi A et al (2012) Aspirin and recurrent venous thromboembolism in patients with symptomatic atherosclerosis. Retrospective cohort study. J Thromb Haemost 10:2205\u20132206","journal-title":"J Thromb Haemost"},{"key":"108_CR44","doi-asserted-by":"crossref","first-page":"e003135","DOI":"10.1136\/bmjopen-2013-003135","volume":"3","author":"CD Nguyen","year":"2013","unstructured":"Nguyen CD, Andersson C, Jensen TB et al (2013) Statin treatment and risk of recurrent venous thromboembolism: a nationwide cohort study. BMJ Open 3:e003135","journal-title":"BMJ Open"},{"key":"108_CR45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0037-1612936","volume":"87","author":"G Palareti","year":"2002","unstructured":"Palareti G, Legnani C, Cosmi B, Guazzaloca G, Pancani C, Coccheri S (2002) Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thromb Haemost 87:7\u201312","journal-title":"Thromb Haemost"},{"key":"108_CR46","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/01.CIR.0000079162.69615.0F","volume":"108","author":"G Palareti","year":"2003","unstructured":"Palareti G, Legnani C, Cosmi B et al (2003) Predictive value of D-Dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idioipathic event and in carriers of congenital thrombophilia. Circulation 108:313\u2013318","journal-title":"Circulation"},{"key":"108_CR47","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1056\/NEJMoa054444","volume":"355","author":"G Palareti","year":"2006","unstructured":"Palareti G, Cosmi B, Legnani C et al (2006) D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med 355:1780\u20131789","journal-title":"N Engl J Med"},{"key":"108_CR48","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1182\/blood-2014-01-548065","volume":"124","author":"G Palareti","year":"2014","unstructured":"Palareti G, Cosmi B, Legnani C et al (2014) D-dimer and residual thrombosis to guide the duration of anticoagulation in patients with venous thromboembolism. A management study. Blood 124:196\u2013203","journal-title":"Blood"},{"doi-asserted-by":"crossref","unstructured":"Pesavento R, Filippi L, Pagnan A et al (2014) Unexpectedly high recanalization rate in patients with pulmonary embolism treated with anticoagulants alone. Am J Respir Crit Care Med 189:1277\u20131279","key":"108_CR49","DOI":"10.1164\/rccm.201312-2251LE"},{"key":"108_CR50","first-page":"515","volume":"87","author":"F Piovella","year":"2002","unstructured":"Piovella F, Crippa L, Barone M et al (2002) Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosis. Haematologica 87:515\u2013522","journal-title":"Haematologica"},{"unstructured":"Prandoni P, Lensing AWA, Prins MH et al (2015). The impact of residual thrombosis on the long-term outcome of patients with deep-vein thrombosis. Submitted 41:133\u2013140","key":"108_CR51"},{"key":"108_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-125-1-199607010-00001","volume":"125","author":"P Prandoni","year":"1996","unstructured":"Prandoni P, Lensing AWA, Cogo A et al (1996) The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 125:1\u20137","journal-title":"Ann Intern Med"},{"key":"108_CR53","doi-asserted-by":"crossref","first-page":"955","DOI":"10.7326\/0003-4819-137-12-200212170-00008","volume":"137","author":"P Prandoni","year":"2002","unstructured":"Prandoni P, Lensing AW, Prins MH et al (2002) Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med 137:955\u2013960","journal-title":"Ann Intern Med"},{"key":"108_CR54","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3324\/haematol.10516","volume":"91","author":"P Prandoni","year":"2007","unstructured":"Prandoni P, Noventa F, Ghirarduzzi A et al (2007) The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1626 patients. Haematologica 91:199\u2013205","journal-title":"Haematologica"},{"key":"108_CR55","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-150-9-200905050-00003","volume":"150","author":"P Prandoni","year":"2009","unstructured":"Prandoni P, Prins MH, Lensing AW et al (2009) Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial. Ann Intern Med 150:577\u2013585","journal-title":"Ann Intern Med"},{"key":"108_CR56","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1111\/j.1538-7836.2010.04039.x","volume":"8","author":"P Prandoni","year":"2010","unstructured":"Prandoni P, Santos JT, S\u00e1nchez-Cantalejo E et al (2010) Major bleeding as a predictor of mortality in patients with venous thromboembolism. J Thromb Haemost 8:2475\u20132477","journal-title":"J Thromb Haemost"},{"key":"108_CR57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.113.004768","volume":"129","author":"RE Roach","year":"2014","unstructured":"Roach RE, Lijfering WM, Rosendaal FR, Cannegieter SC, le Cessie S (2014) Sex difference in risk of second but not of first venous thrombosis: paradox explained. Circulation 129:51\u201356","journal-title":"Circulation"},{"key":"108_CR58","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1503\/cmaj.080493","volume":"179","author":"MA Rodger","year":"2008","unstructured":"Rodger MA, Kahn SR, Wells PS et al (2008) Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ 179:417\u2013426","journal-title":"CMAJ"},{"key":"108_CR59","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/jth.12604","volume":"12","author":"M Schmidt","year":"2014","unstructured":"Schmidt M, Cannegieter SC, Johannesdottir SA, Dekkers OM, Horv\u00e1th-Puh\u00f3 E, S\u00f8rensen HT (2014) Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case-control study. J Thromb Haemost 12:1207\u20131215","journal-title":"J Thromb Haemost"},{"key":"108_CR60","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1056\/NEJM199506223322501","volume":"332","author":"S Schulman","year":"1995","unstructured":"Schulman S, Rhedin AS, Lindmarker P et al (1995) A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 332:1661\u20131665","journal-title":"N Engl J Med"},{"key":"108_CR61","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","volume":"361","author":"S Schulman","year":"2009","unstructured":"Schulman S, Kearon C, Kakkar AK et al (2009) Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 361:2342\u20132352","journal-title":"N Engl J Med"},{"key":"108_CR62","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1113697","volume":"368","author":"S Schulman","year":"2013","unstructured":"Schulman S, Kearon C, Kakkar AK et al (2013) Extended Use of dabigatran, warfarin, or placebo in venous thromboembolism. N Engl J Med 368:709\u2013718","journal-title":"N Engl J Med"},{"key":"108_CR63","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/CIRCULATIONAHA.113.004450","volume":"129","author":"S Schulman","year":"2014","unstructured":"Schulman S, Kakkar AK, Goldhaber SZ et al (2014) Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis. Circulation 129:764\u2013772","journal-title":"Circulation"},{"key":"108_CR64","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1001\/jama.2009.853","volume":"301","author":"JB Segal","year":"2009","unstructured":"Segal JB, Brotman DJ, Necochea AJ et al (2009) Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review. JAMA 301:2472\u20132485","journal-title":"JAMA"},{"key":"108_CR65","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood-2008-01-131656","volume":"112","author":"S Siragusa","year":"2008","unstructured":"Siragusa S, Malato A, Anastasio R et al (2008) Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the \u201cDACUS\u201d study. Blood 112:511\u2013515","journal-title":"Blood"},{"key":"108_CR66","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1538-7836.2009.03279.x","volume":"7","author":"HT S\u00f8rensen","year":"2009","unstructured":"S\u00f8rensen HT, Horvath-Puho E, S\u00f8gaard KK et al (2009) Arterial cardiovascular events, statins, low dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study. J Thromb Haemost 7:521\u2013528","journal-title":"J Thromb Haemost"},{"key":"108_CR67","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archinternmed.2007.69","volume":"168","author":"FA Spencer","year":"2008","unstructured":"Spencer FA, Gore JM, Lessard D, Douketis JD, Emery C, Goldberg RJ (2008) Patient outcomes after deep vein thrombosis and pulmonary embolism: the Worcester Venous thromboembolism study. Arch Intern Med 168:425\u2013430","journal-title":"Arch Intern Med"},{"key":"108_CR68","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1111\/j.1538-7836.2005.01648.x","volume":"3","author":"M Stain","year":"2005","unstructured":"Stain M, Sch\u00f6nauer V, Minar E et al (2005) The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease. J Thromb Haemost 3:2671\u20132676","journal-title":"J Thromb Haemost"},{"key":"108_CR69","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1365-2141.2011.08578.x","volume":"153","author":"M Tan","year":"2011","unstructured":"Tan M, Mos IC, Klok FA, Huisman MV (2011) Residual venous thrombosis as predictive factor for recurrent venous thromboembolim in patients with proximal deep vein thrombosis: a sytematic review. Br J Haematol 153:168\u2013178","journal-title":"Br J Haematol"},{"key":"108_CR70","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","volume":"363","author":"The Einstein Investigators","year":"2010","unstructured":"The Einstein Investigators (2010) Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 363:2499\u20132510","journal-title":"N Engl J Med"},{"key":"108_CR71","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","volume":"366","author":"The Einstein Investigators","year":"2012","unstructured":"The Einstein Investigators (2012) Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 366:1287\u20131297","journal-title":"N Engl J Med"},{"key":"108_CR72","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","volume":"369","author":"The Hokusai-VTE Investigators","year":"2013","unstructured":"The Hokusai-VTE Investigators (2013) Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med 369:1406\u20131415","journal-title":"N Engl J Med"},{"key":"108_CR73","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1538-7836.2012.04735.x","volume":"10","author":"A Tosetto","year":"2012","unstructured":"Tosetto A, Iorio A, Marcucci M et al (2012) Predicting disease recurrence in patients with previous unprovoked venous thromboembolism. A proposed prediction score (DASH). J Thromb Haemost 10:1019\u20131025","journal-title":"J Thromb Haemost"},{"key":"108_CR74","doi-asserted-by":"crossref","first-page":"481","DOI":"10.7326\/0003-4819-149-7-200810070-00008","volume":"149","author":"M Verhovsek","year":"2008","unstructured":"Verhovsek M, Douketis JD, Yi Q et al (2008) Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann Intern Med 149:481\u2013490","journal-title":"Ann Intern Med"},{"key":"108_CR75","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMe1211480","volume":"367","author":"TE Warkentin","year":"2012","unstructured":"Warkentin TE (2012) Aspirin for dual prevention of venous and arterial thrombosis. N Engl J Med 367:2039\u20132041","journal-title":"N Engl J Med"},{"key":"108_CR76","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1538-7836.2012.04635.x","volume":"10","author":"AE Warkentin","year":"2012","unstructured":"Warkentin AE, Donadini MP, Spencer FA, Lim W, Crowther M (2012) Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis. J Thromb Haemost 10:512\u2013520","journal-title":"J Thromb Haemost"},{"key":"108_CR77","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1538-7836.2003.00038.x","volume":"1","author":"A Weltermann","year":"2003","unstructured":"Weltermann A, Eichinger S, Bialonczyk C et al (2003) The risks of recurrent venous thromboembolism among patients with high factor IX levels. J Thromb Haemost 1:28\u201332","journal-title":"J Thromb Haemost"},{"key":"108_CR78","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1160\/TH12-10-0743","volume":"109","author":"B Z\u00f6ller","year":"2013","unstructured":"Z\u00f6ller B, Ohlsson H, Sundquist J, Sundquist K (2013) Familial risk of venous thromboembolism in first-, second- and third-degree relatives: a nationwide family study in Sweden. Thromb Haemost 109:458\u2013463","journal-title":"Thromb Haemost"}],"container-title":["Advances in Experimental Medicine and Biology","Thrombosis and Embolism: from Research to Clinical Practice"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/5584_2016_108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T00:37:09Z","timestamp":1568335029000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/5584_2016_108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319221076","9783319221083"],"references-count":78,"URL":"https:\/\/doi.org\/10.1007\/5584_2016_108","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2016]]}}}